diethylstilbestrol has been researched along with masoprocol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bor, A; Gal, S; Lichtenberg, D; Pinchuk, I | 1 |
| Kawatani, M; Khan, MM; Lai, NS; Osada, H; Shimizu, T; Simizu, S | 1 |
3 other study(ies) available for diethylstilbestrol and masoprocol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Copper-induced peroxidation of phosphatidylserine-containing liposomes is inhibited by nanomolar concentrations of specific antioxidants.
Topics: Antioxidants; Butylated Hydroxytoluene; Chromans; Cinnamates; Copper; Curcumin; Depsides; Diethylstilbestrol; Flavonoids; Liposomes; Luteolin; Masoprocol; Nanotechnology; Naphthols; Phenol; Phosphatidylcholines; Phosphatidylserines; Rosmarinic Acid; Structure-Activity Relationship | 2007 |
Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120.
Topics: Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Estrone; High-Throughput Screening Assays; HIV Envelope Protein gp120; Humans; Masoprocol; Models, Molecular; Molecular Structure; Molecular Weight; Oxidation-Reduction; Parabens; Protein Disulfide-Isomerases; Protein Folding; Sesquiterpenes; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship | 2011 |